Ustekinumab Market Forecast Indicates Strong Long-Term Outlook for U.S. Autoimmune Care
The Ustekinumab Market forecast shows promising growth, driven by rising autoimmune diagnoses across the U.S. and expanding therapeutic applications. Patients continue to favor biologics that deliver reliable disease control with fewer injections, and ustekinumab’s dosing interval gives it a strong competitive advantage. The biologic’s performance in moderate-to-severe cases has...
0 Yorumlar 0 hisse senetleri 11 Views 0 önizleme